Sign in to view content

To Treat or Not to Treat: Are We Sacrificing Treatment Outcomes by Allowing Diabetic Retinopathy (DR) to Enter the Proliferative Stage?

Michael J. Elman, MD

Video
Published 2018

Related

Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2018
Part 2: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 2 of 3)
Arshad M. Khanani, MD, MA, FASRS
Carl J Danzig, MD
On Demand Cases, Courses, and Papers
2018
Clinical Feasibility of Ultra-rapid, Non-pharmacologic Anesthesia for Intravitreal Injection in Patients Receiving Anti-VEGF Treatment
Cagri G Besirli, MD, PhD, FASRS
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

2018 Annual Meeting

See more